Safety and Efficacy of Buparlisib (BKM120) in Patients With Untreated Squamous Non-small Cell Lung Cancer
Clinical trial NCT01820325 · TERMINATED
Trial details
- NCT number
- NCT01820325
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-09
- Primary completion
- 2014-06-18
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.